ES8305378A1 - "procedimiento de obtencion de derivados tiolicos de la eritromicina y del ester propionico de la eritromicina". - Google Patents

"procedimiento de obtencion de derivados tiolicos de la eritromicina y del ester propionico de la eritromicina".

Info

Publication number
ES8305378A1
ES8305378A1 ES510029A ES510029A ES8305378A1 ES 8305378 A1 ES8305378 A1 ES 8305378A1 ES 510029 A ES510029 A ES 510029A ES 510029 A ES510029 A ES 510029A ES 8305378 A1 ES8305378 A1 ES 8305378A1
Authority
ES
Spain
Prior art keywords
erythromycin
pharmaceutical compositions
compositions containing
therapeutic activity
thiolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES510029A
Other languages
English (en)
Other versions
ES510029A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of ES510029A0 publication Critical patent/ES510029A0/es
Publication of ES8305378A1 publication Critical patent/ES8305378A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE DERIVADOS TIOLICOS DE LA ERITROMICINA Y DEL ESTER PROPIONICO DE LA ERITROMICINA. CONSISTE EN HACER REACCIONAR LA ERITROMICINA BASE O SU ESTER PROPIONICO CON UN ACIDO, EN UN DISOLVENTE TAL COMO LA ACETONA O LA METILISOBUTILCETONA A UNA TEMPERATURA COMPRENDIDA ENTRE 20 C Y 40 C EN PRESENCIA DE AGUA; LA CANTIDAD DE AGUA PRESENTE EN EL SOLVENTE, NO ES SUPERIOR AL 20% EN VOLUMEN DEL SOLVENTE DE REACCION, ESTANDO PREFERENTEMENTE COMPRENDIDA ENTRE 4 Y 5%. SE OBTIENEN COMPUESTOS DE FORMULA R-X EN QUE R ES EL RADICAL (I) Y X ES EL RADICAL DE LA ERITROMICINA (II).
ES510029A 1982-01-20 1982-02-02 "procedimiento de obtencion de derivados tiolicos de la eritromicina y del ester propionico de la eritromicina". Expired ES8305378A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8200821A FR2519988B1 (fr) 1982-01-20 1982-01-20 Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent

Publications (2)

Publication Number Publication Date
ES510029A0 ES510029A0 (es) 1983-05-01
ES8305378A1 true ES8305378A1 (es) 1983-05-01

Family

ID=9270148

Family Applications (1)

Application Number Title Priority Date Filing Date
ES510029A Expired ES8305378A1 (es) 1982-01-20 1982-02-02 "procedimiento de obtencion de derivados tiolicos de la eritromicina y del ester propionico de la eritromicina".

Country Status (4)

Country Link
US (1) US4476120A (es)
ES (1) ES8305378A1 (es)
FR (1) FR2519988B1 (es)
IT (1) IT1193039B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173441B (it) * 1984-03-14 1987-06-24 Edmond Pharma Srl Sali di eritromicina con derivati dell'acido acetico,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
CA2164955A1 (en) * 1993-06-18 1995-01-05 Richard J. Sharpe Method for treating hyperkeratosis and diseases mediated by proteases
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
GB2320431B (en) * 1996-12-20 2000-08-30 Johnson & Johnson Medical Compositions for the treatment of chronic wounds
CA2346870A1 (en) 1998-10-20 2000-04-27 Lauteral Limited Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity
AU775565B2 (en) * 1999-10-29 2004-08-05 Novartis Ag Dry powder compositions having improved dispersivity
US6566401B2 (en) * 2001-03-30 2003-05-20 The Board Of Trustees Of The Leland Stanford Junior University N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2653899A (en) * 1952-04-14 1953-09-29 Lilly Co Eli Erythromycin, its salts, and method of preparation
US2743268A (en) * 1952-07-12 1956-04-24 Lilly Co Eli Erythromycin-penicillin
US2830982A (en) * 1955-06-03 1958-04-15 Abbott Lab Water-soluble salt of erythromycin
US3558594A (en) * 1968-09-04 1971-01-26 Abbott Lab Erythromycin aliphatic sulfate
GB1250045A (en) * 1969-01-15 1971-10-20 Pierrel Spa A new water soluble derivative of erythromycin
US3847896A (en) * 1973-04-09 1974-11-12 Upjohn Co Erythromycin-2-thiol esters and process
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf
US4261982A (en) * 1977-11-09 1981-04-14 The Procter & Gamble Company Therapeutic composition
US4264765A (en) * 1980-02-20 1981-04-28 Abbott Laboratories Salts of erythromycin A esters

Also Published As

Publication number Publication date
FR2519988A1 (fr) 1983-07-22
ES510029A0 (es) 1983-05-01
IT8219409A0 (it) 1982-02-02
IT1193039B (it) 1988-06-02
US4476120A (en) 1984-10-09
FR2519988B1 (fr) 1985-06-14

Similar Documents

Publication Publication Date Title
AU588629B2 (en) Medicaments to combat chronic graft-versus-host diseases and to combat autoimmune diseases, in particular systemic lupus erythematosus
DE3069559D1 (en) Beta-carbolin-3-carboxylic acid derivatives, pharmaceutical compositions containing them and their therapeutical use
AU556039B2 (en) I.v. therapy or hyperalimentation catheter
EP0315978A3 (en) New use of 11,28-dioxa-4-azatricyclo û22.3.1.0 4,9¨octacos-18-ene derivatives and pharmaceutical compositions containing them
EP0222483A3 (en) Use of gamma-linolenic acid and related compounds in the treatment of endometriosis
NZ195517A (en) Imidazole-5-acetic acid derivatives and pharmaceutical compositions
PH20380A (en) Mandelic acid derivatives and mandelonitriles, and their use for combating microorganisms
PH16413A (en) Quinazoline derivatives,their pharmaceutical compositions and use
DE3068803D1 (en) The use of 2-phenyltetralin derivatives, or heterocyclic analogues, in medicine and pharmaceutical compositions containing them
DK0531413T3 (da) Et antiviralt præparat indeholdende prostratin
EP0133766A3 (en) Coumarin derivatives, pharmaceutical compositions containing the same, and the use thereof in the treatment of cancer
ES8305001A1 (es) "procedimiento de preparacion de derivados tiolicos de erotromicina y del ester propionico de eritromicina".
ES8305378A1 (es) "procedimiento de obtencion de derivados tiolicos de la eritromicina y del ester propionico de la eritromicina".
IE801563L (en) Stable benzoyl peroxide compositions
ZA884622B (en) Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance
AU617998B2 (en) Anticoccidial composition
NZ194178A (en) Tripeptide derivatives with immunostimulant activity and pharmaceutical compositions
PH15743A (en) Quinazoline derivatives,their pharmaceutical compositions and their use
IL84551A (en) Peptides,their preparation and pharmaceutical compositions containing them
PH15625A (en) Pyridazopyridazine derivatives,their pharmaceutical compositions and their use
JPS5620588A (en) 66alkyll77phenyll1*66naphthylidinee5*6h**one derivative* its manufacture and drug as active component thereof
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
JPS56140923A (en) Nutrient composition and administration thereof
ES469648A1 (es) Un procedimiento para preparar derivados de oleandomicina
Akman Hacettepe Bulletin of Medicine Surgery